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Abstract
Background: We have previously set up an in vitro mesenchymal-epithelial cell co-culture model
which mimics the intestinal crypt villus axis biology in terms of epithelial cell differentiation. In this
model the fibroblast-induced epithelial cell differentiation from secretory crypt cells to absorptive
enterocytes is mediated via transforming growth factor-β (TGF-β), the major inhibitory regulator
of epithelial cell proliferation known to induce differentiation in intestinal epithelial cells. The aim
of this study was to identify novel genes whose products would play a role in this TGF-β-induced
differentiation.
Results: Differential display analysis resulted in the identification of a novel TGF-β upregulated
mRNA species, the Sin3-associated protein 30-like, SAP30L. The mRNA is expressed in several
human tissues and codes for a nuclear protein of 183 amino acids 70% identical with Sin3 associated
protein 30 (SAP30). The predicted nuclear localization signal of SAP30L is sufficient for nuclear
transport of the protein although mutating it does not completely remove SAP30L from the nuclei.
In the nuclei SAP30L concentrates in small bodies which were shown by immunohistochemistry to
colocalize with PML bodies only partially.
Conclusions: By reason of its nuclear localization and close homology to SAP30 we believe that
SAP30L might have a role in recruiting the Sin3-histone deacetylase complex to specific
corepressor complexes in response to TGF-β, leading to the silencing of proliferation-driving genes
in the differentiating intestinal epithelial cells.
Background
The intestinal epithelium is a constantly renewing popu-
lation of cells, which arise from the proliferating stem
cells in the crypts of Lieberkuhn. In the intestinal mucosa
the secretory crypt cells differentiate to absorptive entero-
cytes while migrating along the villus side to the villus tip.
One of the most important modulators of intestinal epi-
thelial cell differentiation is transforming growth factor-β
(TGF-β), which affects the cell cycle machinery leading to
terminal differentiation [1]. This acquisition of differenti-
ated phenotype in epithelial cells requires finely tuned
gene expression where the genes that drive proliferation
are silenced while genes whose products are essential for
a differentiated cell are activated.
We have previously shown by differential display PCR
(DD-PCR) technique [2] that in a cell culture model,
where differentiation of crypt-like T84 cells to enterocyte-
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expression parallel those seen in differentiating intestinal
epithelial cells in vivo [4]. In addition, a novel gene, apop-
tosis antagonizing transcription factor (AATF) (accession
number HSA249940), whose expression was downregu-
lated by TGF-β, was cloned from the undifferentiated
crypt-like cells of the same cell culture system [5]. AATF is
involved in epithelial cell proliferation, since it represses
the growth suppression function of the retinoblastoma
protein (Rb) [6] by inhibiting the recruitment of the his-
tone deacetylase HDAC1 to the Rb/E2F complex [7].
The acetylation status of the histone proteins mainly
responsible for the packing of chromatin plays a key role
in transcriptional regulation. Acetylation of lysine resi-
dues in the histone tails is associated with a more open
chromatin state and thus increased DNA accessibility to
transcription factors [reviewed in [8]], while deacetylation
or histone hypoacetylation is associated with tightly
packed chromatin and transcriptional silencing [9,10].
Both transcriptional coactivators and corepressors regu-
late gene expression by influencing the histone acetyla-
tion status. Histone deacetylation is indeed a basic and
well-conserved mechanism for gene silencing and it
involves many corepressor proteins that vary depending
on the repressor complex. The corepressor may well estab-
lish the target specificity of a given deacetylase complex as
in the case of the Rb protein. It recruits a histone deacety-
lase complex to E2F transcription factors, leading to the
repression of transcription of E2F-dependent target genes
[11].
In this paper we now for the first time describe the initial
characterization of another unknown transcript identified
by DD-PCR in differentiating intestinal T84 epithelial
cells. The newly identified gene codes for a protein mark-
edly similar to the histone deacetylase-associated core-
pressor Sin3-associated protein 30 (SAP30), and therefore
this novel Sin3-associated protein 30-like, SAP30L, could
well have a role in silencing the genes crucial for prolifer-
ation in intestinal crypt epithelial cells.
The expression of SAP30L in control and TGF-β-treated dif-fer ntiated T84 epithelial cellsFigure 1
The expression of SAP30L in control and TGF-β-treated dif-
ferentiated T84 epithelial cells. The lower panel shows that in 
DD-PCR the band representing SAP30L was present solely in 
the RNA sample from the differentiated T84 cells. Real time 
quantitative PCR verified this differential expression to be 2.0 
times higher (SEM ± 0.13).
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SAP30L mRNA expression in human tissuesFigure 2
SAP30L mRNA expression in human tissues. Northern 
hybridization to a multi-tissue northern blot showed that a 
1.3 kB transcript is expressed in all tissues examined, with 
higher expression in the testis and weaker in the liver and 
lung. A transcript of size 6.5 kB was abundantly expressed in 
brain and lung but not at all in liver and stomach. The lower 
panel shows the control hybridization with an β-actin specific 
probe.
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DD-PCR showed that TGF-β1 induced consistent and
reproducible upregulation of a transcript denoted SAP30L
(see later) (Figure 1) using the arbitrary 5' primer AP-3
and the 3' anchoring primer T12MG. Quantitative RT-
PCR using LightCycler technology verified this induction
by TGF-β in three independent experiments. The differen-
tiated TGF-β-treated cells expressed this transcript 2.0
times more than the unstimulated T84 cells (Figure 1).
Sequence analysis of this transcript showed that SAP30L is
identical with an mRNA transcribed from the gene
FLJ11526 located in chromosome 5q33.2. The gene has
four exons and the expected size of the transcribed mRNA
is 1281 base pairs. Indeed, northern hybridization to a
multi-tissue northern blot showed that a SAP30L-specific
probe recognized an mRNA of approximately 1.3 kB (Fig-
ure 2). The mRNA was expressed in all tissues examined,
with somewhat weaker expression in the liver and lung
and particularly abundant expression in the testis. Inter-
estingly, there was also a transcript of size 6.5 kB which
was abundantly expressed in brain and lung but not at all
in liver and stomach. As the genomic sequence did not
predict an mRNA of this size, its identity remains to be
established.
Screening of a heart cDNA library in order to find the
whole-length transcript resulted in identification of a
positive clone with an insert of size 1.3 kB. When the
clone was sequenced and compared to the sequence of an
Image clone FLJ11526, the two sequences were found to
be identical. Both clones code for a protein of 183 amino
acids (Figure 3), which was named Sin3-associated pro-
tein 30 like, SAP30L. Prosite scan identified two putative
N-glycosylation sites (NASF, amino acids 44–47 and
NKSR, amino acids 168–171), one N-myristoylation site
(GQSCCL, amino acids 26–31) and several phosphoryla-
tion sites for different kinases. The PsortII program pre-
dicted the SAP30L protein to be nuclear, the putative
nuclear localization signal being KRKRK, ranging from
amino acid 87 to 91 (Figure 3). A database search for
homologous proteins showed that SAP30L has ortho-
logues in several species (Figure 4). The corresponding
mouse protein is 97% identical with the human SAP30L.
The Xenopus protein is 85% identical along the first 150
amino acids after which they begin to diversify considera-
bly while the Drosophila melanogaster orthologue is fairly
identical along the whole protein, the identity being 52%.
Interestingly, there was a human protein called SAP30,
which was 70% identical with SAP30L. Amino acid com-
parison of SAP30L with SAP30 showed SAP30 to have in
its N-terminus a 38-amino-acid stretch that was absent in
SAP30L. The corresponding SAP30 protein was also
found in mouse but not in other species.
In transient transfection experiments on IMR-90 fibrob-
lasts we were able to show that the wild-type SAP30L-
EGFP fusion protein is indeed nuclear and concentrates in
small dense bodies (Figure 5a). The transfection of the
EGFP fusion protein, which had only the putative nuclear
localization and six flanking amino acids on either side
(pEGFP-NLS), also resulted in the nuclear localization of
the protein (Figure 5b), thus providing evidence for the
functionality of the signal. Mutation in the nuclear locali-
zation signal (NLS) (KRKRK → KSNRK) disturbed this
nuclear localization to some extent, causing the protein to
be visible also in the cytosol although it did not com-
pletely inhibit the protein's nuclear transport (Figure 5c).
Immunocytochemical staining of these transfected cells
with anti-promyelotocytic leukaemia (PML) antibody
showed these nuclear structures to be other than PML
bodies (Figure 5d).
Discussion
We describe here the cloning of a novel human TGF-β-
upregulated mRNA from differentiated T84 epithelial
cells. The novel mRNA is approximately 1.3 kB long and
was ubiquitously expressed in all tissues examined. The
protein, called SAP30L, is 183 amino acids in length and
located in the nucleus, where it concentrates in small
dense structures other than PML bodies.
The amino acid sequence of SAP30LFigure 3
The amino acid sequence of SAP30L. SAP30L had an open reading frame of 183 amino acids. The PsortII-predicted N-glycosyla-
tion sites are in italics, the N-myristoylation site is underlined and the nuclear localization signal is boxed.
MNGFSTEEDSREGPPAAPAAAAPGYGQSCCLIEDGERCVRPAGNASFSKRVQKSISQKKLKLDIDKSVRHLYICDFH
KNFIQSVRNKRKRKTSDDGGDSPEHDTDIPEVDLFQLQVNTLRRYKRHYKLQTRPGFNKAQLAETVSRHFRNIPVNE
KETLAYFIYMVKSNKSRLDQKSEGGKQLEPage 3 of 8
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SAP30, the most prominent difference being the lack of
38 amino acids in the N terminus of SAP30L. At the
genomic level, although their DNA sequences differ, their
exon-intron organization is exactly the same, which sug-
gests a common evolutionary origin for these genes. It
would appear that SAP30L is evolutionarily older than
SAP30, since only mammals have the protein with the
extra 38 N-terminal amino acids. The size of for example
the Drosophila orthologue corresponds better with the size
of SAP30L than with SAP30.
Based on the extremely high degree of identity in the pri-
mary structure of SAP30L and SAP30 it is probable that
they also share functional similarity. SAP30 is a 30 kD
nuclear protein associated with the Sin3 corepressor
Multiple alignment of SAP30L with its orthologues and SAP30 proteins of human and mouseFigure 4
Multiple alignment of SAP30L with its orthologues and SAP30 proteins of human and mouse. All six proteins are highly identical 
except for the 38 amino acids which appear in SAP30 of human, and mouse. Asterisks mark identical amino acids, colons and 
periods designate conservative substitutions.
SAP30L -MNGFSTEEDSR--------------------------------------
Mus musculus EST -MNGFSTEEDSR--------------------------------------
Xenopus laevis -MNGFSTEEDSR--------------------------------------
Drosophila melanogaster     MNNGFSTGEEDS--------------------------------------
Homo sapiens SAP30 -MNGFTPEEMSRGGDAAAAVAAVVAAAAAAASAGNGNAAGGGAEVPGAGA
Mus musculus SAP      MNGFTPDEMSRGGDAAAAVAAVVAAAAAAASAGNGTGAGTGAEVPGAGA
                                    ***:. * .                              
SAP30L     EGPPAAPAAAAPGYGQSCCLIEDGERCVRPAGNASFSKRVQKSISQKKLK
Mus musculus EST     EGPPAAPAAAP-GYGQSCCLIADGERCVRPAGNASFSKRVQKSISQKKLK
Xenopus laevis     DGP---PAQAAPFFGQTCCLIDGGERCPRPAGNASFSKRVQKSISQKKLK
Drosophila melanogaster ----------RGHTDQTCCLIDDMERCRNQAGYASYSKRIQKTVAQKRLK 
Homo sapiens SAP30     VSASGPPGAAGPGPGQLCCLREDGERCGRAAGNASFSKRIQKSISQKKVK
Mus musculus SAP     VSAAGPPGAAGPGPGQLCCLREDGERCGRAAGNASFSKRIQKSISQKKVK
                                                .* ***  . *** . ** **:***:**:::**::*
SAP30L     LDIDKSVRHLYICDFHKNFIQSVRNKRKRKTSDD-GGDSPEHDTDIPEV-
Mus musculus EST     LDIDKSVRHLYICDFHKNFIQSVRNKRKRKASDD-GGDSPEHDADIPEV-
Xenopus laevis     LDIDKNVRHLYICDFHKNYIQSVRNKRKRKTSDD-GGDSPEHETDIPEV-
Drosophila melanogaster     LSSDPAAQHIYICDHHKERIQSVRTKRRRKDSED---DSNETDTDLHEFP 
Homo sapiens SAP30     IELDKSARHLYICDYHKNLIQSVRNRRKRKGSDDDGGDSPVQDIDTPEV-
Mus musculus SAP     IELDKSARHLYICDYHKNLIQSVRNRRKRKGSDDDGGDSPVQDIDTPEV-
                                  :. *  .:*:****.**: *****.:*:** *:*   **   : *  *. 
SAP30L     DLFQLQVNTLRRYKRHYKLQTRPGFNKAQLAETVSRHFRNIPVNEKETLA
Mus musculus EST     DLFQLQVNTLRRYKRHYKLQTRPGFNKAQLAETVSRHFRNIPVNEKETLA
Xenopus laevis     DLFQLQVNTLRRYKRYYKLQTRPGLNKAQLAEVLFNSERTLINVVHETKF
Drosophila melanogaster     DLYQLGVSTLRRYKRHFKVQTRQGMKRAQLADTIMKHFKTIPIKEKEIIT 
Homo sapiens SAP30     DLYQLQVNTLRRYKRHFKLPTRPGLNKAQLVEIVGCHFKSIPVNEKDTLT
Mus musculus SAP     DLYQLQVNTLRRYKRHFKLPTRPGLNKAQLVEIVGCHFRSIPVNEKDTLT
                                  **:** *.*******::*: ** *:::***.: :    :.:    ::   
SAP30L     YFIYMVKSNKSRLDQKSEGGKQLE
Mus musculus EST     YFIYMVKSNRSRLDQKSEGSKQLE
Xenopus laevis     LINKIIKGVVHLSNTFIS------
Drosophila melanogaster     FFVYMVKMGSNKLDQKNGLGNDTT 
Homo sapiens SAP30  CFIYSVRNDKNKSDLKADSGVH--
Mus musculus SAP     YFIYSVKNDKNKSDLKVDSGVH--
                                   :   ::      :          Page 4 of 8
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and 2, SAP18, RbAp46 and RbAp48 proteins [14]. The
Sin3 complex facilitates transcriptional repression by
being recruited to specific sites by different DNA-binding
transcription factors [15,16] such as Mad, Ikaros, p53 and
nuclear hormone receptors [17]. SAP30 is involved in the
interaction at least in the case of nuclear hormone
receptors, where it is thought to act as a specificity factor
stabilizing or facilitating the interaction between the
DNA-binding N-CoR and Sin3A [14]. SAP30 binds to N-
CoR by its 129 N-terminal amino acids and to Sin3 with
amino acids 129–220 [14]. Since the C-terminal part of
SAP30L and SAP30 are markedly similar but SAP30L lacks
38 amino acids in the N-terminus when compared to
SAP30, SAP30L is likely to bind Sin3A but not N-CoR.
Further evidence for the binding of SAP30L to mSin3a
comes from a recent study by Fleischer and associates [18]
where they identified a novel 28 kD protein which binds
to mSin3a. The identified protein is very probably
SAP30L. In the Sin3 repressor complex SAP30L might
work similarly to SAP30 eg to recruit Sin3a to other repres-
sor complexes than N-CoR.
The recruitment of the Sin3-HDAC repressor complex to
E2-dependent promoters leads to exit from the cell cycle,
thus allowing differentiation to occur [19]. TGF-β pro-
motes exit from cell cycle in many ways, for example by
directly inhibiting the expression of c-myc [20], which is
mediated by proteins E2F4/5, Smads and p107 [21]. P107
is a pocket protein able to bind to HDACs. It is interesting
Transfection of the different EGFP fusion constructs to IMR-90 fibroblastsFigur  5
Transfection of the different EGFP fusion constructs to IMR-90 fibroblasts. A) The wild-type SAP30L concentrates in small 
dense bodies in the nuclei. B) The nuclear localization of the fusion protein with only the NLS of SAP30L provides evidence for 
the functionality of the nuclear localization signal. C) Mutating the NLS disrupts the nuclear localization of the protein to some 
extent. D) Anti-PML-antibody staining (red) of wild-type SAP30L-transfected cells shows that the nuclear concentrates are 
other than PML bodies.
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in order to fulfil its role in the stabilization of the Sin3
repressor complex in E2F-dependent promoter sites to
repress transcription of proliferation-associated genes
such as c-myc and may thus have a crucial role in
differentiation.
Conclusions
In conclusion, we report here the identification of a novel
transcript, SAP30L, which encodes a protein that very
likely has a role in a histone deacetylase complex. Since
the protein is 70% identical with a previously known
protein SAP30 it might function similarly to SAP30, e.g. in
recruiting Sin3A to a specific repressor complex other than
N-CoR, leading to the silencing of proliferation-driving
gene(s) and ultimately to the differentiation of the intes-
tinal epithelial cells.
Methods
Cell lines and cultures
Human intestinal epithelial T84 cells (CCL 248) were pur-
chased from the American Type Culture Collection (Rock-
ville, MD). The cells were cultured in Dulbecco's modified
Eagle medium and Ham's F-12 (1:1) (Gibco BRL, Paisley,
Scotland) supplemented with 5% foetal calf serum (FCS)
and antibiotics (500 IU/ml penicillin and 100 µg/mL
streptomycin; Gibco BRL). Three-dimensional type I col-
lagen gel cultures were conducted as previously described
[3]. Differentiation of T84 cells was induced by adding 20
ng/ml of human recombinant TGF-β1 (hTGF-β1, R&D
Systems Europe, Oxon, UK) to the cultures and the cul-
tures were kept in 5% CO2 at 37°C for seven days.
The human embryonic lung fibroblast cell line IMR-90
(CCL 186) was purchased from the American Type Cul-
ture Collection. The cells were cultured in basal medium
(Eagle) supplemented with 10% FCS, 0.075% NaHCO3
and 2 mmol/l glutamine.
RNA isolation and differential display PCR
Total RNA was isolated from control and hTGF-β1-treated
three-dimensionally cultured T84 cells with TRIzol rea-
gent (Gibco BRL) as instructed by the manufacturer and
subjected to DNase I (Roche Molecular Biochemicals,
Indianapolis, IN) treatment, after which they were
extracted with phenol-chloroform-isoamylalcohol (Sigma
Chemical Co., St. Louis, MO). DD-PCR was done accord-
ing to the RNAmap™ protocol (GenHunter Corporation,
Nashville, TN) with arbitrary 5' primers and anchoring 3'
primers. The reactions were repeated twice with newly
purified RNA in order to confirm the reproducibility of
the results. The differentially expressed transcripts were
recovered from the gel and sequenced using the ABI
PRISM Dye Terminator Cycle Sequencing Ready Reaction
Kit (Perkin Elmer, Foster City, CA) as instructed by the
manufacturer.
Primers
The primers used in different experiments are shown in
Table 1 and were purchased from either Genset Oligos
(Paris, France) or TAG Copenhagen (Copenhagen,
Denmark).
Quantitative PCR
Differential expression was confirmed using LightCycler
technology in three independent RNA populations. One
microgram of the Dnase I-treated total RNA was reverse-
transcribed to cDNA using SuperScript II reverse tran-
scriptase (Gibco BRL) with 0.5 µg of oligo(dT) primer.
This cDNA was then subjected to PCR using a LightCycler
Fast Start Cyber Green kit (Roche Diagnostics, Espoo, Fin-
land) according to manufacturer's instructions. The prim-
ers 3EX3S and 3EX4AS (see Table 1) were used at a
concentration of 0.5 µM. The cycling conditions were as
follows; 96C 10 min followed by 45 cycles at 96C 10 s,
57C 10 s and 72C 10 s. The relative amounts of the
unknown samples (control and TGF-β treated) were cal-
culated by setting their cross points to the standard curve
generated by a serial dilution of cDNA produced from T84
cells. The expression level of SAP30L in undifferentiated
and differentiated T84 cells was normalized by the house-
keeping gene glyceraldehyde dehydrogenase.
Screening of cDNA library for the whole length transcript
A human heart cDNA library (Rapid-Screen Arrayed
cDNA Library Panel; OriGene Technologies, Rockville,
MD) was screened by PCR using primers 3EX3S and
3EX4AS. The conditions of the PCR amplification for both
Master Plate and Sub-plates were as follows: 95°C for 5
min, followed by 40 cycles of denaturation at 95°C for 45
s, annealing at 57°C for 30 s, and extension at 72°C for
60 s with a final extension at 72°C for 5 minutes. For the
third round of screening, PCR was performed on single
bacterial colonies. DNA from positive clones was
sequenced using both vector- and gene-specific primers
indicated in the table. The accession number for SAP30L
is AY341060
Northern hybridization
A SAP30L specific PCR fragment was labelled with [α-
32P]dATP (Amersham Pharmacia Biotech, Amersham,
UK) using Strip-Ez DNA™ Random Primed StribAble™
DNA probe synthesis and removal kit (Ambion, Austin,
USA) according to manufacturer's instructions and
hybridised to human 12 tissue northern blot (Origene
Technologies). A β-actin specific probe served as a positive
control.Page 6 of 8
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The nucleic acid sequence and the deduced amino acid
sequence were searched against the NCBI Blast database
[22]. PSORTII server [23] was used to predict the subcel-
lular localization of the SAP30L protein and to identify
the putative peptide responsible for this localization.
Construction of EGFP expression vectors and transfection
Wild-type SAP30L cDNA was cloned into the pEGFP-C1
(Clontech, Palo Alto CA) expression vector by polymerase
chain reaction using primers (Table 1) with EcoRI and
HindIII restriction sites at the 5'- and 3' ends, respectively.
The mutation to the putative nuclear localization signal
was generated by PCR using two complementary oligos
(Table 1) bearing the mutated sequence (R88→S and
K89→N) and the previously mentioned primers with
EcoRI and HindIII restriction sites for cloning the insert
into the EGFP vector. In addition, for generation of the
pEGFP-NLS construct a double-stranded oligo containing
the predicted consensus nuclear localization signal plus
six flanking amino acids on either terminus was ordered
from TAG Copenhagen and cloned into pEGFP-C1.
5 × 104 cells were plated on chamber slides (Nalge Nunc,
Rochester, NY) and cultured for 24 hours prior to transfec-
tion with 1 µg of the appropriate EGFP construct and Tfx-
50 reagent (Promega, Madison, WI) for 2 hour. Detection
of the green fluorescence protein by confocal microscopy
(Ultraview Confocal Imaging System, PerkinElmer Life
Sciences Inc., Boston, MA) was performed 24 hours after
transfection.
Immunocytochemistry
Expression of the PML protein in transfected IMR-90
fibroblasts was detected using a commercial antibody PG-
M3 (Santa Cruz Biotechnology Inc, Santa Cruz, CA). The
transfected cells were fixed with methanol 24 hours after
transfection, whereafter the non-specific binding of
antibodies was blocked with normal serum. The anti-
PML-antibody was diluted 1:50 and incubated for one
hour. The TRITC-conjugated anti-mouse secondary serum
(1:200) (Dako A/S, Glostrup, Denmark) was incubated
for an hour before the slides were dried and mounted with
50% glycerol in PBS. To assess the overlapping of the
EGFP-emitted green and TRITC-emitted red fluorescence
the slides were studied under a confocal microscope and
the images were merged.
Abbreviations
TGF-β, transforming growth factor-β; DD-PCR, differen-
tial display PCR; AATF, apoptosis antagonising transcrip-
tion factor; Rb, retinoblastoma; SAP30, Sin3-associated
protein 30; SAP30L, Sin3-associated protein 30-like; PML,
promyelocytic leukaemia; FCS, foetal calf serum
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Table 1: Primers used in the study.
Primer Sequence (5'→3') Method Company
FLJforward CCCAAGCTTGGGGCGGGGAGATGAACGGCTTC EGFP-PCR Genset Oligos
FLJreverse CCGGAATTCTCAAGCTGCTTGCCACCCTCCGA EGFP-PCR Genset Oligos
EX1S AGCACGGAGGAGGACAGCCGCGAA Sequencing Genset Oligos
EX2S GTAAGGCACCTATATATCTGTGAT Sequencing Genset Oligos
EX2AS GTGTCGTGCTCGGGAGAATCTCCG Sequencing Genset Oligos
EX3S GTTGATCTGTTCCAGCTGCAGGTG Library screening LightCycler
Northern probe
Genset Oligos
EX3AS TTCTGCTAACTGGGCCTTATTGAA Sequencing Genset Oligos
EX4AS TCAAGCTGCTTGCCACCCTCCGA Library screening LightCycler
Northern probe
Genset Oligos
3G3TNLSfor CGAAATAAAAGTAACAGGAAGACAAGT NLS mutation TAG Copenhagen
3G3TNLSrev ACTTGTCTTCCTGTTACTTTTATTTCG NLS mutation TAG Copenhagen
The table indicates the names and sequences of the primers used in given experiments.Page 7 of 8
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